Skip to main content

RIJ to Market Sloning's Gene Synthesis Services in Japan

NEW YORK (GenomeWeb News) — Sloning Biotechnology of Puchheim, Germany, on Monday said that Research and Innovation Japan will exclusively market and distribute its Slonomics gene-synthesis service and its Slonomax gene-mutant libraries in Japan.
 
“Sloning's products and services perfectly address the current demand in genomics research and protein engineering,” RIJ CEO Kiyohiko Hirasawa said in a statement.
 
Financial terms of the agreement were not released.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.